INCY — Incyte Corporation · P/E 14, rev $5.14B

Incyte Corporation (INCY) is a biotechnology company listed on US.

Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.

Use this INCY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INCY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INCY SEC filings page. Lician reads the product cache first so this HTML stays unique to Incyte Corporation even when a live quote feed is slow.

Incyte Corporation latest statements (FY2025)

Latest cached year on this hub. Full INCY income, balance, and cash tables.

  • Revenue$5.14B
  • Net Income$1.29B
  • Total Assets$6.96B
  • Total Debt$0
  • Free Cash Flow$0

INCY recent filings